发明名称 |
FGFR INHIBITOR FOR USE IN THE TREATMENT OF THE PHOSPHATURIC MESENCHYMAL TUMOR |
摘要 |
The present invention relates generally to 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimid-4-yl}-1-methyl-urea or a pharmaceutically acceptable salt or a pharmaceutical composition comprising 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimid-4-yl}-1-methyl-urea or a pharmaceutically acceptable salt for use in the treatment of phosphaturic mesenchymal tumors. |
申请公布号 |
WO2016189472(A1) |
申请公布日期 |
2016.12.01 |
申请号 |
WO2016IB53056 |
申请日期 |
2016.05.25 |
申请人 |
NOVARTIS AG;GRAUS PORTA, Diana;ISAACS, Randi |
发明人 |
GRAUS PORTA, Diana;ISAACS, Randi |
分类号 |
A61K31/506;A61K31/59;A61K33/06;A61K33/42;A61K38/29;A61K45/06;A61P35/00;A61P35/04 |
主分类号 |
A61K31/506 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|